GeneDx Holdings Corp. (WGS)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ
Market Cap: $1.53B
Last updated: Nov 17, 2026 at 4:32 PM ET
GeneDx Holdings Corp. (WGS) Stock Chart
GeneDx Holdings (WGS) has a latest price of $47.29 on Nov 17, 2026, 72.3% below its 52-week high of $170.87. Its price fell 63.1% over the past 12 months. The month-end price fell 74.1% over the 5 years through Oct 2026, a compound annual decline of 23.7%.
Price Chart
From Nov 2020 to Oct 2026, its highest month-end close was $660.40 in Feb 2021 and its lowest $1.75 in Nov 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart WGS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for WGS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 40.6%, and over 6 months it rose 12.2%. The month-end price rose 3,612.9% over the 3 years through Oct 2026, a compound annual rate of 233.6%.
| Period | Change |
|---|---|
| 1 month | -28.7% |
| 3 months | -40.6% |
| 6 months | +12.2% |
| 12 months | -63.1% |
| 12 months, with dividends | -63.1% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +3,612.9% | +233.6% |
| 5 years | -74.1% | -23.7% |
Price by Year
Its best calendar year was 2024, when the price rose 2,694.9%, and its weakest was 2022, when it fell 94.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $69.06 | -46.9% |
| 2025 | $130.06 | +69.2% |
| 2024 | $76.86 | +2,694.9% |
| 2023 | $2.75 | -68.4% |
| 2022 | $8.71 | -94.1% |
| 2021 | $147.19 | -59.6% |
Trading Range
The price is 34.6% below its 50-day average of $72.36 and 31.9% below its 200-day average of $69.41.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $47.29 | |
| 52-week high | $170.87 | -72.3% |
| 52-week low | $32.21 | +46.8% |
| 50-day average | $72.36 | -34.6% |
| 200-day average | $69.41 | -31.9% |
Price Risk
Over 3 years, its largest fall from a peak was 79.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.63 |
| Largest fall, 1 year | -79.4% |
| Largest fall, 3 years | -79.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About WGS
What is WGS's 1-year price change?
GeneDx Holdings's price fell 63.1% over the past 12 months. With dividends included, the 12-month total return was -63.1%.
What is WGS's 5-year price change?
GeneDx Holdings's month-end price fell 74.1% over the 5 years through Oct 2026, a compound annual decline of 23.7%. These figures leave out dividends.
What is WGS's 52-week high and low?
GeneDx Holdings's 52-week high is $170.87 and its 52-week low is $32.21. Its latest price of $47.29 on Nov 17, 2026 is 72.3% below the high.
What is WGS's beta?
GeneDx Holdings's 1-year beta against the S&P 500 is 1.63, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 79.4%.
Is the WGS chart free?
Yes. Advanced Charting for WGS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
WGS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation